| Literature DB >> 32179913 |
Alexis Diaz-Vegas1,2, Pablo Sanchez-Aguilera1, James R Krycer2, Pablo E Morales1, Matías Monsalves-Alvarez1,3, Mariana Cifuentes1,3,4, Beverly A Rothermel5, Sergio Lavandero1,5,4.
Abstract
Mitochondrial damage is implicated as a major contributing factor for a number of noncommunicable chronic diseases such as cardiovascular diseases, cancer, obesity, and insulin resistance/type 2 diabetes. Here, we discuss the role of mitochondria in maintaining cellular and whole-organism homeostasis, the mechanisms that promote mitochondrial dysfunction, and the role of this phenomenon in noncommunicable chronic diseases. We also review the state of the art regarding the preclinical evidence associated with the regulation of mitochondrial function and the development of current mitochondria-targeted therapeutics to treat noncommunicable chronic diseases. Finally, we give an integrated vision of how mitochondrial damage is implicated in these metabolic diseases. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.Entities:
Keywords: mitochondria; cancer; cardiovascular diseases; insulin resistance; obesity
Mesh:
Substances:
Year: 2020 PMID: 32179913 PMCID: PMC7255501 DOI: 10.1210/endrev/bnaa005
Source DB: PubMed Journal: Endocr Rev ISSN: 0163-769X Impact factor: 19.871